Vincerx Pharma, Inc. Quarterly Return On Equity in % from Q2 2020 to Q2 2024

Taxonomy & unit
ratio: %
Description
Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
Summary
Vincerx Pharma, Inc. quarterly/annual Return On Equity history and growth rate from Q2 2020 to Q2 2024.
  • Vincerx Pharma, Inc. Return On Equity for the quarter ending June 30, 2024 was -270 %, a 106% decline year-over-year.
  • Vincerx Pharma, Inc. annual Return On Equity for 2023 was -188 %, a 102% decline from 2022.
  • Vincerx Pharma, Inc. annual Return On Equity for 2022 was -93 %, a 76.3% decline from 2021.
  • Vincerx Pharma, Inc. annual Return On Equity for 2021 was -52.7 %, a 80.3% increase from 2020.
Return On Equity, Quarterly (%)
Return On Equity, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Start Date End Date
Q2 2024 -270 -139 -106% Apr 1, 2024 Jun 30, 2024
Q1 2024 -301 -187 -165% Jan 1, 2024 Mar 31, 2024
Q4 2023 -188 -94.7 -102% Oct 1, 2023 Dec 31, 2023
Q3 2023 -155 -82.7 -115% Jul 1, 2023 Sep 30, 2023
Q2 2023 -131 -58.7 -81.2% Apr 1, 2023 Jun 30, 2023
Q1 2023 -113 -58.6 -107% Jan 1, 2023 Mar 31, 2023
Q4 2022 -93 -40.3 -76.3% Oct 1, 2022 Dec 31, 2022
Q3 2022 -71.9 +16.1 +18.3% Jul 1, 2022 Sep 30, 2022
Q2 2022 -72.3 +9.26 +11.4% Apr 1, 2022 Jun 30, 2022
Q1 2022 -54.7 +127 +69.9% Jan 1, 2022 Mar 31, 2022
Q4 2021 -52.7 +215 +80.3% Oct 1, 2021 Dec 31, 2021
Q3 2021 -88 -336 -136% Jul 1, 2021 Sep 30, 2021
Q2 2021 -81.5 -183 -181% Apr 1, 2021 Jun 30, 2021
Q1 2021 -181 Jan 1, 2021 Mar 31, 2021
Q4 2020 -267 Oct 1, 2020 Dec 31, 2020
Q3 2020 248 Jul 1, 2020 Sep 30, 2020
Q2 2020 101 Apr 1, 2020 Jun 30, 2020
* An asterisk sign (*) next to the value indicates that the value is likely invalid.